Late relapse of childhood acute lymphoblastic leukemia and pcr-monitoring of minimal residual disease: how much time can elapse between "molecular" and clinical relapse?
Aricò
Maurizio
M
OncoEmatologia Pediatrica, Ospedale dei Bambini "G. Di Cristina", 90100 Palermo, Italy. arico@ospedalecivicopa.org
Germano
Giuseppe
G
del Giudice
Laura
L
Ziino
Ottavio
O
Locatelli
Franco
F
Basso
Giuseppe
G
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001853:Bone Marrow / Q000473:pathology; D002675:Child, Preschool; D002999:Clone Cells / Q000473:pathology; D020732:Cytogenetic Analysis; D005260:Female; D006801:Humans; D018365:Neoplasm, Residual / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis* / Q000188:drug therapy; D011379:Prognosis; D012008:Recurrence; D012074:Remission Induction / Q000379:methods